Detalles de la búsqueda
1.
Effect of the topical administration of N-(2-(4-bromophenylamino)-5-(trifluoromethyl)phenyl)nicotinamide compound in a murine subcutaneous melanoma model.
Anticancer Drugs
; 31(7): 718-727, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32568827
2.
Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.
Toxicol Appl Pharmacol
; 356: 214-223, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30138656
3.
First evidence of a serine arginine protein kinase (SRPK) in leishmania braziliensis and its potential as therapeutic target.
Acta Trop
; 238: 106801, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36563831
4.
Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.
Toxicol In Vitro
; 65: 104777, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31962201
5.
Trifluoromethyl arylamides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs).
Eur J Med Chem
; 134: 97-109, 2017 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407594
6.
Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).
PLoS One
; 10(8): e0134882, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26244849
Resultados
1 -
6
de 6
1
Próxima >
>>